Lager CJ, et al. - Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (LSG) were compared in terms of weight loss and impact on comorbidities. Researchers performed a retrospective evaluation of weight, blood pressure, hemoglobin A1c, cholesterol, and medication use for hypertension, diabetes, and hyperlipidemia at 1–4 years post-operatively in 380 patients who underwent RYGB and 334 patients who underwent LSG at the University of Michigan from January 2008 to November 2013. RYGB was identified to be superior regarding weight loss, reduction in medications for hypertension and diabetes, improvements in markers of diabetes and hyperlipidemia, and remission rates of hypertension compared to LSG 4 years post-operatively. They recommend considering surgical risk, comorbidities, and weight loss goals while deciding bariatric procedure.